| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.615 | 0.025 | 0.615 | Cyclophilin D inhibitor | 0.577 0.032 DBMET02188 | ||
| 0.491 | 0.015 | 0.491 | Platelet antagonist | 0.426 0.023 DBMET02188 | ||
| 0.418 | 0.004 | 0.418 | Prostaglandin antagonist | 0.283 0.005 DBMET02188 | ||
| 0.438 | 0.057 | 0.449 | 5 Hydroxytryptamine release inhibitor | 0.449 0.052 DBMET02188 | DBMET02188 | |
| 0.34 | 0.006 | 0.34 | Succinate dehydrogenase inhibitor | 0.339 0.006 DBMET02188 | ||
| 0.382 | 0.067 | 0.382 | Toll-Like receptor 7 agonist | 0.344 0.085 DBMET02188 | ||
| 0.336 | 0.028 | 0.336 | Platelet aggregation inhibitor | 0.3 0.036 DBMET02188 | ||
| 0.375 | 0.07 | 0.375 | Toll-Like receptor agonist | 0.336 0.089 DBMET02188 | ||
| 0.322 | 0.06 | 0.354 | Sodium/bile acid cotransporter inhibitor | 0.354 0.037 DBMET02188 | DBMET02188 | |
| 0.343 | 0.091 | 0.343 | Antiobesity | 0.266 0.142 DBMET02188 | ||
| 0.253 | 0.005 | 0.363 | Creatine kinase inhibitor | 0.363 0.003 DBMET02188 | DBMET02188 | |
| 0.245 | 0.003 | 0.245 | Guanylate cyclase stimulant | 0.206 0.004 DBMET02188 | ||
| 0.343 | 0.103 | 0.403 | Histamine release inhibitor | 0.403 0.074 DBMET02188 | DBMET02188 | |
| 0.243 | 0.007 | 0.251 | Arachidonic acid antagonist | 0.251 0.005 DBMET02188 | DBMET02188 | |
| 0.271 | 0.035 | 0.277 | Non-steroidal antiinflammatory agent | 0.277 0.033 DBMET02188 | DBMET02188 | |
| 0.322 | 0.102 | 0.322 | GABA C receptor rho-3 antagonist | 0.321 0.102 DBMET02188 | ||
| 0.247 | 0.036 | 0.255 | Insulin sensitizer | 0.255 0.031 DBMET02188 | DBMET02188 | |
| 0.283 | 0.075 | 0.363 | Hypoxia-inducible factor 1 alpha inhibitor | 0.363 0.041 DBMET02188 | DBMET02188 | |
| 0.237 | 0.029 | 0.237 | Antipruritic | 0.233 0.031 DBMET02188 | ||
| 0.27 | 0.065 | 0.307 | Hypoglycemic | 0.307 0.05 DBMET02188 | DBMET02188 | |
| 0.202 | 0.005 | 0.202 | Prostaglandin E2 antagonist | 0.142 0.009 DBMET02188 | ||
| 0.257 | 0.062 | 0.284 | Tyrosine 3 hydroxylase inhibitor | 0.284 0.042 DBMET02188 | DBMET02188 | |
| 0.223 | 0.028 | 0.223 | Alpha-N-acetylglucosaminidase inhibitor | 0.143 0.059 DBMET02188 | ||
| 0.22 | 0.033 | 0.244 | Phospholipase A2 inhibitor | 0.244 0.025 DBMET02188 | DBMET02188 | |
| 0.186 | 0.007 | 0.186 | Cannabinoid CB1 receptor agonist | 0.098 0.02 DBMET02188 | ||
| 0.18 | 0.004 | 0.18 | Prostaglandin D2 antagonist | 0.097 0.005 DBMET02188 | ||
| 0.28 | 0.104 | 0.307 | Cholesterol antagonist | 0.307 0.087 DBMET02188 | DBMET02188 | |
| 0.303 | 0.139 | 0.303 | Analgesic | 0.283 0.155 DBMET02188 | ||
| 0.19 | 0.034 | 0.19 | Cell wall synthesis inhibitor | 0.186 0.037 DBMET02188 | ||
| 0.232 | 0.076 | 0.232 | Hypolipemic | 0.215 0.085 DBMET02188 | ||
| 0.167 | 0.018 | 0.173 | Uric acid excretion stimulant | 0.173 0.017 DBMET02188 | DBMET02188 | |
| 0.158 | 0.011 | 0.158 | Peroxisome proliferator-activated receptor gamma agonist | 0.144 0.014 DBMET02188 | ||
| 0.186 | 0.039 | 0.186 | Hemostatic | 0.18 0.042 DBMET02188 | ||
| 0.193 | 0.047 | 0.193 | Diuretic | 0.169 0.061 DBMET02188 | ||
| 0.157 | 0.016 | 0.157 | ABCA1 expression enhancer | 0.144 0.019 DBMET02188 | ||
| 0.155 | 0.016 | 0.155 | Phosphodiesterase I inhibitor | 0.144 0.018 DBMET02188 | ||
| 0.189 | 0.057 | 0.19 | Thrombolytic | 0.19 0.057 DBMET02188 | DBMET02188 | |
| 0.163 | 0.033 | 0.163 | Ferrochelatase inhibitor | |||
| 0.139 | 0.012 | 0.154 | Aldose reductase inhibitor | 0.154 0.01 DBMET02188 | DBMET02188 | |
| 0.252 | 0.125 | 0.252 | Vasodilator, peripheral | 0.239 0.136 DBMET02188 | ||
| 0.128 | 0.004 | 0.128 | Guanylate cyclase 1 stimulant | 0.064 0.004 DBMET02188 | ||
| 0.215 | 0.093 | 0.234 | Vasodilator | 0.234 0.079 DBMET02188 | DBMET02188 | |
| 0.141 | 0.021 | 0.141 | ErbB-2 antagonist | 0.124 0.026 DBMET02188 | ||
| 0.121 | 0.004 | 0.121 | Prostacyclin antagonist | 0.091 0.005 DBMET02188 | ||
| 0.126 | 0.017 | 0.142 | Myeloperoxidase inhibitor | 0.142 0.013 DBMET02188 | DBMET02188 | |
| 0.154 | 0.047 | 0.18 | Farnesoid X receptor antagonist | 0.18 0.029 DBMET02188 | DBMET02188 | |
| 0.112 | 0.008 | 0.112 | Prostaglandin F2 alpha antagonist | 0.102 0.011 DBMET02188 | ||
| 0.154 | 0.05 | 0.154 | Nav1.6 sodium channel blocker | 0.133 0.076 DBMET02188 | ||
| 0.239 | 0.135 | 0.239 | Antithrombotic | 0.239 0.135 DBMET02188 | ||
| 0.13 | 0.027 | 0.13 | Triose-phosphate isomerase inhibitor | 0.101 0.046 DBMET02188 | ||
| 0.107 | 0.009 | 0.107 | Phosphodiesterase 1C inhibitor | 0.094 0.012 DBMET02188 | ||
| 0.131 | 0.035 | 0.131 | Adenylate kinase inhibitor | 0.098 0.07 DBMET02188 | ||
| 0.144 | 0.049 | 0.144 | Sphingosine 1-phosphate receptor 2 antagonist | 0.132 0.069 DBMET02188 | ||
| 0.103 | 0.009 | 0.103 | Phosphodiesterase 1A inhibitor | 0.077 0.018 DBMET02188 | ||
| 0.114 | 0.02 | 0.116 | Lipase inhibitor | 0.116 0.02 DBMET02188 | DBMET02188 | |
| 0.143 | 0.052 | 0.18 | Aldehyde dehydrogenase inhibitor | 0.18 0.033 DBMET02188 | DBMET02188 | |
| 0.107 | 0.019 | 0.122 | Leukotriene antagonist | 0.122 0.015 DBMET02188 | DBMET02188 | |
| 0.302 | 0.214 | 0.345 | Antiinflammatory | 0.345 0.176 DBMET02188 | DBMET02188 | |
| 0.098 | 0.015 | 0.098 | Phosphodiesterase 1B inhibitor | 0.086 0.019 DBMET02188 | ||
| 0.088 | 0.005 | 0.088 | Prostaglandin EP4 antagonist | 0.049 0.009 DBMET02188 | ||
| 0.132 | 0.05 | 0.21 | Cystathionine beta-synthase inhibitor | 0.21 0.022 DBMET02188 | DBMET02188 | |
| 0.119 | 0.037 | 0.119 | Electrolyte absorption antagonist | |||
| 0.091 | 0.014 | 0.091 | Peroxisome proliferator-activated receptor alpha agonist | 0.079 0.018 DBMET02188 | ||
| 0.087 | 0.011 | 0.087 | Aconitate hydratase inhibitor | 0.053 0.034 DBMET02188 | ||
| 0.152 | 0.076 | 0.173 | Protein-tyrosine phosphatase inhibitor | 0.173 0.061 DBMET02188 | DBMET02188 | |
| 0.133 | 0.058 | 0.133 | Anesthetic local | 0.11 0.075 DBMET02188 | ||
| 0.09 | 0.015 | 0.09 | Thromboxane antagonist | 0.075 0.023 DBMET02188 | ||
| 0.077 | 0.003 | 0.077 | Guanylate cyclase inhibitor | 0.07 0.005 DBMET02188 | ||
| 0.113 | 0.039 | 0.113 | Glutamate (mGluR7) agonist | |||
| 0.217 | 0.145 | 0.217 | Immunomodulator | |||
| 0.079 | 0.007 | 0.079 | CC chemokine 4 receptor antagonist | 0.059 0.017 DBMET02188 | ||
| 0.097 | 0.027 | 0.097 | Cannabinoid receptor agonist | |||
| 0.143 | 0.082 | 0.143 | Insulin secretagoues | 0.135 0.09 DBMET02188 | ||
| 0.097 | 0.036 | 0.173 | Macrophage migration inhibitory factor inhibitor | 0.173 0.01 DBMET02188 | DBMET02188 | |
| 0.069 | 0.009 | 0.083 | Liver X receptor alpha agonist | 0.083 0.006 DBMET02188 | DBMET02188 | |
| 0.068 | 0.01 | 0.068 | Benzodiazepine inverse agonist | 0.056 0.018 DBMET02188 | ||
| 0.066 | 0.01 | 0.083 | Estrogen-related receptor alpha antagonist | 0.083 0.008 DBMET02188 | DBMET02188 | |
| 0.07 | 0.014 | 0.07 | Leukotriene C antagonist | 0.069 0.015 DBMET02188 | ||
| 0.11 | 0.057 | 0.11 | GABA C receptor agonist | |||
| 0.059 | 0.007 | 0.059 | Angiotensin AT1 receptor antagonist | 0.041 0.03 DBMET02188 | ||
| 0.082 | 0.031 | 0.082 | Peroxisome proliferator-activated receptor gamma antagonist | 0.077 0.039 DBMET02188 | ||
| 0.067 | 0.018 | 0.067 | Pregnane X receptor antagonist | 0.061 0.029 DBMET02188 | ||
| 0.213 | 0.164 | 0.252 | Apoptosis antagonist | 0.252 0.126 DBMET02188 | DBMET02188 | |
| 0.14 | 0.095 | 0.148 | Growth hormone agonist | 0.148 0.089 DBMET02188 | DBMET02188 | |
| 0.098 | 0.055 | 0.108 | Bile acid receptor antagonist | 0.108 0.034 DBMET02188 | DBMET02188 | |
| 0.103 | 0.06 | 0.109 | Butyrylcholinesterase inhibitor | 0.109 0.055 DBMET02188 | DBMET02188 | |
| 0.05 | 0.008 | 0.05 | Prostaglandin D2 agonist | 0.045 0.009 DBMET02188 | ||
| 0.111 | 0.069 | 0.133 | Protein-tyrosine phosphatase 1B inhibitor | 0.133 0.054 DBMET02188 | DBMET02188 | |
| 0.135 | 0.095 | 0.135 | Ca2+-transporting ATPase inhibitor | |||
| 0.047 | 0.008 | 0.047 | Angiotensin II receptor antagonist | |||
| 0.071 | 0.032 | 0.071 | Prostaglandin EP2 antagonist | 0.063 0.039 DBMET02188 | ||
| 0.049 | 0.01 | 0.049 | Endothelin receptor antagonist | 0.032 0.016 DBMET02188 | ||
| 0.057 | 0.019 | 0.057 | Sphingosine 1-phosphate receptor agonist | 0.041 0.035 DBMET02188 | ||
| 0.134 | 0.097 | 0.134 | GABA C receptor rho-2 antagonist | 0.128 0.109 DBMET02188 | ||
| 0.071 | 0.035 | 0.071 | MDM2 inhibitor | |||
| 0.095 | 0.059 | 0.095 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.145 | 0.11 | 0.145 | ATPase inhibitor | 0.143 0.114 DBMET02188 | ||
| 0.087 | 0.053 | 0.087 | ErbB-3 antagonist | |||
| 0.045 | 0.011 | 0.045 | Peroxisome proliferator-activated receptor delta antagonist | 0.039 0.015 DBMET02188 | ||
| 0.094 | 0.061 | 0.094 | HIV-1 integrase (Overall Integration) inhibitor | 0.081 0.077 DBMET02188 | ||
| 0.044 | 0.012 | 0.044 | Carnitine palmitoyltransferase 1 inhibitor | 0.035 0.022 DBMET02188 | ||
| 0.044 | 0.012 | 0.044 | Carnitine palmitoyltransferase inhibitor | 0.034 0.024 DBMET02188 | ||
| 0.036 | 0.005 | 0.036 | Prostacyclin agonist | 0.026 0.007 DBMET02188 | ||
| 0.045 | 0.015 | 0.045 | Leukotriene C4 antagonist | 0.044 0.016 DBMET02188 | ||
| 0.124 | 0.094 | 0.13 | Cyclooxygenase inhibitor | 0.13 0.087 DBMET02188 | DBMET02188 | |
| 0.033 | 0.004 | 0.033 | Thyroid hormone alpha agonist | 0.033 0.004 DBMET02188 | ||
| 0.077 | 0.047 | 0.089 | Glutamate decarboxylase inhibitor | 0.089 0.037 DBMET02188 | DBMET02188 | |
| 0.042 | 0.014 | 0.044 | Liver X receptor beta agonist | 0.044 0.013 DBMET02188 | DBMET02188 | |
| 0.072 | 0.046 | 0.072 | Phosphofructokinase-1 inhibitor | |||
| 0.033 | 0.01 | 0.055 | Thyroid hormone agonist | 0.055 0.004 DBMET02188 | DBMET02188 | |
| 0.132 | 0.109 | 0.156 | Mcl-1 antagonist | 0.156 0.084 DBMET02188 | DBMET02188 | |
| 0.058 | 0.035 | 0.058 | Bombesin 3 receptor antagonist | |||
| 0.14 | 0.118 | 0.156 | Platelet adhesion inhibitor | 0.156 0.099 DBMET02188 | DBMET02188 | |
| 0.091 | 0.07 | 0.091 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.042 | 0.021 | 0.044 | CF transmembrane conductance regulator antagonist | 0.044 0.017 DBMET02188 | DBMET02188 | |
| 0.12 | 0.1 | 0.256 | Peroxidase inhibitor | 0.256 0.046 DBMET02188 | DBMET02188 | |
| 0.074 | 0.055 | 0.078 | GABA B receptor agonist | 0.078 0.046 DBMET02188 | DBMET02188 | |
| 0.029 | 0.01 | 0.029 | Prostaglandin EP1 antagonist | 0.018 0.015 DBMET02188 | ||
| 0.045 | 0.027 | 0.045 | Liver X receptor agonist | 0.045 0.028 DBMET02188 | ||
| 0.044 | 0.026 | 0.044 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.089 | 0.073 | 0.14 | Xanthine oxidase inhibitor | 0.14 0.038 DBMET02188 | DBMET02188 | |
| 0.054 | 0.038 | 0.054 | Thromboxane synthase inhibitor | |||
| 0.027 | 0.011 | 0.027 | Endothelin A receptor antagonist | 0.019 0.017 DBMET02188 | ||
| 0.048 | 0.033 | 0.048 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.102 | 0.089 | 0.102 | Caspase 3 inhibitor | |||
| 0.048 | 0.035 | 0.055 | Plasminogen activator inhibitor antagonist | 0.055 0.027 DBMET02188 | DBMET02188 | |
| 0.082 | 0.07 | 0.082 | NADH dehydrogenase inhibitor | 0.079 0.078 DBMET02188 | ||
| 0.073 | 0.061 | 0.073 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.065 | 0.053 | 0.065 | Glutamate (mGluR6) antagonist | |||
| 0.038 | 0.028 | 0.038 | Urate transporter 1 inhibitor | 0.035 0.031 DBMET02188 | ||
| 0.049 | 0.038 | 0.049 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.029 | 0.022 | 0.029 | Prostaglandin EP3 antagonist | |||
| 0.148 | 0.141 | 0.259 | Aldehyde oxidase inhibitor | 0.259 0.079 DBMET02188 | DBMET02188 | |
| 0.054 | 0.048 | 0.054 | Biliverdin reductase inhibitor | |||
| 0.135 | 0.13 | 0.14 | Lipocortins synthesis antagonist | 0.14 0.121 DBMET02188 | DBMET02188 | |
| 0.175 | 0.17 | 0.261 | Lipoxygenase inhibitor | 0.261 0.093 DBMET02188 | DBMET02188 | |
| 0.065 | 0.061 | 0.065 | Porphobilinogen synthase inhibitor | |||
| 0.129 | 0.125 | 0.135 | Heat shock protein 70 antagonist | 0.135 0.094 DBMET02188 | DBMET02188 | |
| 0.019 | 0.016 | 0.019 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.016 | 0.014 | 0.016 | Free fatty acid receptor 1 agonist | |||
| 0.053 | 0.051 | 0.053 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.044 | 0.041 | 0.044 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.125 | 0.122 | 0.15 | Dual specificity phosphatase 3 inhibitor | 0.15 0.097 DBMET02188 | DBMET02188 | |
| 0.056 | 0.054 | 0.056 | NMDA receptor agonist | |||
| 0.031 | 0.029 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.033 0.026 DBMET02188 | DBMET02188 | |
| 0.03 | 0.028 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.05 | 0.048 | 0.05 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.06 | 0.058 | 0.068 | Phenylalanine 4-hydroxylase inhibitor | 0.068 0.049 DBMET02188 | DBMET02188 | |
| 0.054 | 0.053 | 0.054 | NMDA receptor glycine site agonist | |||
| 0.031 | 0.03 | 0.031 | Purinergic P2X3 antagonist | |||
| 0.008 | 0.007 | 0.017 | Thyroid hormone beta agonist | 0.017 0.004 DBMET02188 | DBMET02188 | |
| 0.119 | 0.119 | 0.121 | Hexokinase inhibitor | 0.121 0.117 DBMET02188 | DBMET02188 | |
| 0.084 | 0.086 | 0.103 | Interleukin 12 antagonist | 0.103 0.048 DBMET02188 | DBMET02188 | |
| 0.069 | 0.071 | 0.1 | Estrogen receptor alpha antagonist | 0.1 0.027 DBMET02188 | DBMET02188 | |
| 0.197 | 0.2 | 0.209 | Immunosuppressant | 0.209 0.188 DBMET02188 | DBMET02188 | |
| 0.046 | 0.05 | 0.076 | Xanthine dehydrogenase inhibitor | 0.076 0.027 DBMET02188 | DBMET02188 | |
| 0.09 | 0.094 | 0.1 | Nav1.4 sodium channel blocker | 0.1 0.077 DBMET02188 | DBMET02188 | |
| 0.046 | 0.051 | 0.055 | Alcohol oxidase inhibitor | 0.055 0.04 DBMET02188 | DBMET02188 | |
| 0.012 | 0.018 | 0.015 | Thyroid hormone alpha antagonist | 0.015 0.011 DBMET02188 | DBMET02188 | |
| 0.078 | 0.084 | 0.097 | Alcohol dehydrogenase inhibitor | 0.097 0.055 DBMET02188 | DBMET02188 | |
| 0.135 | 0.143 | 0.156 | Neurotensin receptor agonist | 0.156 0.087 DBMET02188 | DBMET02188 | |
| 0.135 | 0.145 | 0.151 | Catenin beta inhibitor | 0.151 0.105 DBMET02188 | DBMET02188 | |
| 0.045 | 0.057 | 0.051 | Leukotriene B4 antagonist | 0.051 0.043 DBMET02188 | DBMET02188 | |
| 0.121 | 0.136 | 0.14 | Dual specificity phosphatase inhibitor | 0.14 0.107 DBMET02188 | DBMET02188 | |
| 0.086 | 0.102 | 0.119 | DNA polymerase I inhibitor | 0.119 0.069 DBMET02188 | DBMET02188 | |
| 0.068 | 0.084 | 0.089 | NMDA receptor antagonist | 0.089 0.055 DBMET02188 | DBMET02188 | |
| 0.074 | 0.097 | 0.084 | Thioredoxin inhibitor | 0.084 0.072 DBMET02188 | DBMET02188 | |
| 0.142 | 0.173 | 0.162 | Spasmolytic | 0.162 0.152 DBMET02188 | DBMET02188 | |
| 0.185 | 0.218 | 0.209 | Interleukin 2 agonist | 0.209 0.175 DBMET02188 | DBMET02188 | |
| 0.071 | 0.106 | 0.089 | Estrogen-related receptor beta agonist | 0.089 0.043 DBMET02188 | DBMET02188 | |
| 0.081 | 0.12 | 0.146 | Amylase inhibitor | 0.146 0.066 DBMET02188 | DBMET02188 | |
| 0.164 | 0.21 | 0.249 | Transcription factor NF kappa B inhibitor | 0.249 0.128 DBMET02188 | DBMET02188 | |
| 0.085 | 0.132 | 0.104 | Acetylcholinesterase inhibitor | 0.104 0.099 DBMET02188 | DBMET02188 | |
| 0.08 | 0.128 | 0.108 | DOPA decarboxylase inhibitor | 0.108 0.061 DBMET02188 | DBMET02188 | |
| 0.146 | 0.195 | 0.171 | Superoxide dismutase inhibitor | 0.171 0.155 DBMET02188 | DBMET02188 | |
| 0.132 | 0.19 | 0.25 | Antioxidant | 0.25 0.083 DBMET02188 | DBMET02188 | |
| 0.058 | 0.121 | 0.095 | Bronchodilator | 0.095 0.069 DBMET02188 | DBMET02188 | |
| 0.08 | 0.143 | 0.109 | Cyclooxygenase 3 inhibitor | 0.109 0.091 DBMET02188 | DBMET02188 | |
| 0.048 | 0.115 | 0.063 | HIV-1 integrase inhibitor | 0.063 0.061 DBMET02188 | DBMET02188 | |
| 0.1 | 0.187 | 0.135 | Melanin inhibitor | 0.135 0.106 DBMET02188 | DBMET02188 | |
| 0.194 | 0.284 | 0.271 | Calcium channel L-type activator | 0.271 0.184 DBMET02188 | DBMET02188 | |
| 0.075 | 0.166 | 0.107 | Toll-Like receptor 2 antagonist | 0.107 0.094 DBMET02188 | DBMET02188 | |
| 0.067 | 0.162 | 0.09 | Toll-Like receptor 4 antagonist | 0.09 0.088 DBMET02188 | DBMET02188 | |
| 0.05 | 0.146 | 0.086 | 5-Lipoxygenase inhibitor | 0.086 0.075 DBMET02188 | DBMET02188 | |
| 0.044 | 0.146 | 0.1 | Monophenol monooxygenase inhibitor | 0.1 0.076 DBMET02188 | DBMET02188 | |
| 0.069 | 0.189 | 0.134 | Estrogen antagonist | 0.134 0.033 DBMET02188 | DBMET02188 | |
| 0.196 | 0.326 | 0.259 | Caspase 9 stimulant | 0.259 0.243 DBMET02188 | DBMET02188 | |
| 0.014 | 0.217 | 0.03 | Estrogen-related receptor beta antagonist | 0.03 0.028 DBMET02188 | DBMET02188 | |
| 0.067 | 0.313 | 0.188 | Free radical scavenger | 0.188 0.108 DBMET02188 | DBMET02188 | |
| 0.02 | 0.463 | 0.101 | Estrogen receptor beta antagonist | 0.101 0.062 DBMET02188 | DBMET02188 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |